One of our most popular biohacks is NAD+ therapy
Sunbasket Managing type 2 diabetes is one of many reasons that someone might be prescribed a GLP-1
Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn
On the one hand, ID represents a major cause of hypothyroidism worldwide, and it also favors the development of goiter and thyroid nodules [6, 17, 23]
An important regulatory note: On December 22, 2025, the FDA approved Novo Nordisk's Wegovy tablet (oral semaglutide 25 mg) as the first oral GLP-1 receptor agonist for chronic weight management, with a national launch in January 2026
Gestational Diabetes: Women with a history of diabetes during pregnancy are at an increased risk of developing Type 2 diabetes later in life